NeuroPace Inc (NPCE): R&D Expense
$27.89M
Year ended 2025-12-31
$27.69M
Trailing 12 months to 2026-06-30
+8.3%
3-year compound annual growth
+12.2%
5-year compound annual growth
| Period ended | R&D Expense | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $27.89M | +17.9% | 2026-03-03, From 2025-01-01 |
| 2024-12-31 | $23.65M | +13.8% | 2026-03-03, From 2024-01-01 |
| 2023-12-31 | $20.78M | -5.3% | 2025-03-04, From 2023-01-01 |
| 2022-12-31 | $21.95M | +20.5% | 2024-03-05, From 2022-01-01 |
| 2021-12-31 | $18.21M | +16.0% | 2023-03-02, From 2021-01-01 |
| 2020-12-31 | $15.70M | n/a | 2022-03-10, From 2020-01-01 |
R&D Expense at similar companies
| Company | Year ended | R&D Expense | Change YoY |
|---|---|---|---|
| NeuroPace Inc (NPCE) | 2025-12-31 | $27.89M | +17.9% |
| Beta Bionics, Inc. (BBNX) | 2025-12-31 | $34.79M | +32.9% |
| Kestra Medical Technologies, Ltd. (KMTS) | 2026-04-30 | $19.48M | +24.5% |
| Pulmonx Corp (LUNG) | 2025-12-31 | $19.49M | +10.9% |
| Anika Therapeutics, Inc. (ANIK) | 2025-12-31 | $25.77M | +0.9% |
| Orasure Technologies Inc (OSUR) | 2025-12-31 | $42.53M | +63.3% |
| Delcath Systems, Inc. (DCTH) | 2025-12-31 | $29.25M | +110.8% |
| Iradimed Corp (IRMD) | 2025-12-31 | $2.98M | +5.0% |
| TELA Bio, Inc. (TELA) | 2025-12-31 | $9.22M | +4.6% |
Compare NPCE, BBNX, KMTS, LUNG side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗